The recent advancements in psychedelic-assisted therapy, particularly with substances like psilocybin, signal a promising horizon for treating depression. At Philadelphia Integrative Psychiatry, we are already familiar with the transformative potential of psychedelic therapies through our use of ketamine-assisted treatment.

Doxepin is a medication primarily used in the treatment of depression and anxiety disorders. This handout aims to provide you with an overview of Doxepin, including its effectiveness, dosing guidelines etc.

Viibryd (vilazodone) is an FDA-approved medication for treating major depressive disorder (MDD) in adults, known for its faster action compared to many other antidepressants.

These findings, published in JAMA Psychiatry, highlight the gut-brain axis as a novel target for depression treatment, supporting the idea that a balanced microbiome can positively affect mental health.

The home use of transcranial direct current stimulation (tDCS) as a potential remedy for depressive symptoms, results revealed a disappointing lack of improvement.

In the journey towards depression relief, artistic healing stands out as a beacon of hope.

This commitment is crucial as we explore the neurobiological aspects of depression, including the potential role of membrane potential dysregulation, to enhance our integrative approach to mental health care.